Fairman Group »

Castle Biosciences shares owned by Fairman Group

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Fairman Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $287 13 22.15
2023-12-31 $281 13 21.62

More positions owned by Fairman Group

Accenture Plc Ireland Shs Class A (ACN)
Ishares Tr Core S&p500 Etf (IVV)
Accolade (ACCD)
Essent (ESNT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
W.R. Berkley Corporation (WRB)
Veeva Sys Cl A Com (VEEV)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Eafe Etf (EFA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)

View all positions for Fairman Group

Top funds holding Castle Biosciences

Daniel D. Thurber
Principal Financial Group
Vanguard Group
Bellevue Group
Deerfield Management Company
Portolan Capital Management
Millennium Management
Dimensional Fund Advisors
Kornitzer Capital Management
Palisade Capital Management
Jacobs Levy Equity Management
Citadel Advisors
New York State Common Retirement Fund
Charles Schwab Investment Management
Banque Pictet & Cie Sa

View all funds holding Castle Biosciences